BOSTON, Mass. – Lendlease was recently selected to provide construction management services for Pfizer’s new biologics clinical manufacturing facility in Andover, Massachusetts.
On June 16, Pfizer broke ground for the 175,000-square-foot, state-of-the-art facility that will enable the production of high-quality, complex biologics and vaccines.
The new clinical manufacturing facility is designed with five independent manufacturing suites to support Pfizer’s highly complex and diverse biologics research effort. The facility will:
- Employ flexible design to fully enable next generation manufacturing strategies
- Leverage state-of-the-art, single-use bioreactors and disposable process technologies
- Provide clinical manufacturing options with the lowest cost and greatest flexibility for efficiently driving important clinical drugs to patients
Lendlease has been operating in the Boston metro area for more than 20 years and within this region completed the first single-use cell culture manufacturing facility in the United States, which received the Facility of the Year Award – Honorable Mention from the ISPE Interphex consortium in 2011.
Join our thriving community of 70,000+ superintendents and trade professionals on LinkedIn!
Search our job board for your next opportunity, or post an opening within your company.
Subscribe to our monthly
Construction Superintendent eNewsletter and stay current. 
